Discovery of a PD-L1-directed ISAC optimized for the activation of PD-L1-expressing myeloid cells to drive potent antitumor immune responses

PD-L1 ISAC - Bolt Biotherapeutics

https://jitc.bmj.com/content/13/Suppl_2/A1121

Po Y Ho 1; Rishali K Gadkari 2; Shahid Khan 3; Jennifer E Melrose 4; David T Omstead 5; Katelynn A McEachin 6; Quyen Thach 7; Karla A Henning 8; William G Mallet 9; Romas A Kudirka 10; Michael N Alonso 11; Justin A Kenkel 12

Oct 3, 2025